Product Details
CIMZIA 2x200 mg/ml PFS Kit
Manufacturer: UCB PHARMA
MFG#: 50474-0710-79
NDC: 50474-0710-79
PID: 636801
1/UN
$ *.**
In StockAdditional Information
| Product Name | Cimzia 2X200 Mg/Ml Pfs Kit |
| Therapeutic Class | Tumor Necrosis Factor (TNF) Inhibitor |
| Active Ingredient | Certolizumab Pegol |
| Mechanism of Action | Binds and neutralizes TNF-alpha to reduce inflammation |
| Strength | 200 mg/mL |
| Dosage Form | Prefilled Syringe (PFS) |
| Route of Administration | Subcutaneous (SC) Injection |
| Half-Life | ~14 days, extended due to pegylation |
| Immunogenicity | Lower than other TNF inhibitors due to lack of Fc region |
| Common Side Effects | Injection site reactions, infections, headache, nausea |
| Monitoring Requirements | TB screening, liver function, complete blood count |
| Storage Conditions | Refrigerate at 2°C to 8°C (36°F to 46°F), protect from light |
| Prescription Requirement | Prescription only |
| Packaging | 2 prefilled syringes per kit |
| Indications | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, non-radiographic axial spondyloarthritis |
Description
Cimzia 200 mg/mL Prefilled Syringe Kit is a tumor necrosis factor (TNF) inhibitor used in the treatment of autoimmune diseases. It contains certolizumab pegol, a pegylated monoclonal antibody fragment that selectively binds to TNF-alpha, preventing its interaction with cell surface receptors. This inhibition reduces inflammation, immune response overactivity, and disease progression in chronic inflammatory conditions.
This medication is indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and non-radiographic axial spondyloarthritis. It is administered as a subcutaneous injection, typically requiring a loading dose followed by maintenance dosing based on the condition being treated.
Common side effects include injection site reactions, infections, headache, and gastrointestinal discomfort. Serious risks include increased susceptibility to infections, malignancies, and hypersensitivity reactions. Regular monitoring of complete blood counts, liver function, and tuberculosis screening is required before and during treatment to ensure patient safety.
Frequently Asked Questions (FAQs)
The cost of CIMZIA 2x200 mg/ml PFS Kit is $$0.00
CIMZIA 2x200 mg/ml PFS Kit is manufactured by UCB PHARMA.
You can purchase CIMZIA 2x200 mg/ml PFS Kit on our website at https://supplies.pipelinemedical.com/product/detail/cimzia-kt-2x200mg-pfs-636801